# Adrenergic Neuron Blockers

## Examples

- `reserpine`
- `guanethidine`
- `guanadrel` _(obsolete)_
- `bethanidine` _(obsolete)_

> They lower BP **by depleting norepinephrine**, but cause **depression, hypotension, and GI effects**, so they’re now **obsolete** for modern hypertension therapy!!!

## Mechanism of Action (MOA)

| Drug                             | Site / Mechanism                                                                                                                                                                                                                                                                                                                                   |
| :------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **`Reserpine`**                  | - Enters adrenergic nerve terminals and **irreversibly blocks vesicular monoamine transporter (VMAT)**. <br/> - Prevents storage of **norepinephrine (NE), dopamine, serotonin** in vesicles. <br/> - NE is metabolized by **MAO** → depletion of NE in both central & peripheral neurons. <br/> - Result: ↓ sympathetic tone → ↓ heart rate & BP. |
| **`Guanethidine` / `Guanadrel`** | - Taken up into adrenergic nerve terminals via **uptake-1 (NE transporter)**. <br/> - **Displaces NE** from vesicles and **prevents its release** on nerve stimulation. <br/> - Acts peripherally (does _not_ cross BBB). <br/> - Result: progressive depletion of peripheral NE → ↓ sympathetic vasoconstrictor tone.                             |

## Pharmacodynamics (Effects)

- ↓ Peripheral vascular resistance (vasodilation).
- ↓ Heart rate and cardiac output.
- **Marked postural hypotension** due to sympathetic blockade.
- **No central sedation** with `guanethidine` (doesn’t cross BBB).
- **Marked CNS depression** with `reserpine` (crosses BBB → serotonin & dopamine depletion).

## Pharmacokinetics

| Drug           | Absorption / Distribution / Metabolism                                                                                        |
| :------------- | :---------------------------------------------------------------------------------------------------------------------------- |
| `Reserpine`    | Oral, well absorbed; long-acting (effect persists for days–weeks due to irreversible VMAT blockade). Crosses BBB.             |
| `Guanethidine` | Oral; poor CNS penetration. Uptake into neurons required for activity (blocked by TCAs or cocaine). Slowly excreted in urine. |

## Indications

- **Historical use:** Moderate to severe **hypertension** (before newer drugs).
- **Current use:**
  - `Reserpine` — occasionally in **low-dose combinations** in resource-limited settings.
  - Otherwise **obsolete** for hypertension.

## Adverse Effects

| System                | Effect / Explanation                                          |
| :-------------------- | :------------------------------------------------------------ |
| **CNS** (`reserpine`) | Sedation, depression, suicidal tendencies (↓ CNS monoamines). |
| **Cardiovascular**    | Postural hypotension, bradycardia.                            |
| **Gastrointestinal**  | Diarrhea, gastric ulceration (↑ vagal tone).                  |
| **Sexual**            | Erectile dysfunction, retrograde ejaculation.                 |
| **Nasal / Eyes**      | Nasal stuffiness, miosis.                                     |
| **Miscellaneous**     | Fluid retention, weight gain (sympathetic suppression).       |

## Cautions

- Avoid in **depression**, **peptic ulcer disease**, **elderly (risk of falls)**.
- Avoid concurrent **tricyclic antidepressants or cocaine** with `guanethidine` — they block neuronal uptake, preventing its action.
- Should not be combined with **sympathomimetic drugs** (opposite mechanism).

## Contraindications

- **Depressive disorders** (`reserpine`).
- **Peptic ulcer disease**.
- **Parkinson’s disease** (reserpine depletes dopamine).
- **Severe postural hypotension**.
